Association of perioperative red blood cell transfusions with venous thromboembolism in a North American Registry

JAMA Surgery

Volumn 153, Issue 9, 2018, Pages 826-833

  Goel, Ruchika ^a   Patel, Eshan U ^b   Cushing, Melissa M ^a   Frank, Steven M ^c   Ness, Paul M ^b   Takemoto, Clifford M ^d   Vasovic, Ljiljana V ^a   Sheth, Sujit ^a   Nellis, Marianne E ^a   Shaz, Beth ^e   Tobian, Aaron A R ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL OUTCOME; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ERYTHROCYTE TRANSFUSION; FEMALE; GENERAL SURGERY; GYNECOLOGIC SURGERY; HUMAN; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NEUROSURGERY; NORTH AMERICAN; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; REGISTER; SURGICAL PATIENT; SURGICAL RISK; THORAX SURGERY; UROLOGIC SURGERY; VASCULAR SURGERY; VENOUS THROMBOEMBOLISM; ADOLESCENT; ADVERSE EVENT; CLINICAL TRIAL; FOLLOW UP; INCIDENCE; NORTH AMERICA; ODDS RATIO; POSTOPERATIVE COMPLICATION; PROCEDURES; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURGERY; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NORTH AMERICA; ODDS RATIO; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; UNITED STATES; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 85052601383     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2018.1565     Document Type: Article

References (45)

1. Centers for Disease Control and Prevention. Venous thromboembolism (blood clots): data and statistics on HA-VTE. https://www.cdc.gov/ncbddd/dvt/ha-vte-data.html. Reviewed April 6, 2017. Accessed April 26, 2018.
2. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107 (23)(suppl 1):I9-I16.
3. Lau BD, Haut ER. Practices to prevent venous thromboembolism: a brief review. BMJ Qual Saf. 2014;23(3):187-195.
4. Zeidan AM, Streiff MB, Lau BD, et al. Impact of a venous thromboembolism prophylaxis “smart order set”: improved compliance, fewer events. Am J Hematol. 2013;88(7):545-549.
5. Cook D, Crowther M, Meade M, et al. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med. 2005;33(7):1565-1571.
6. Fleming FJ, Kim MJ, Salloum RM, Young KC, Monson JR. How much do we need to worry about venous thromboembolism after hospital discharge? a study of colorectal surgery patients using the National Surgical Quality Improvement Program database. Dis Colon Rectum. 2010;53(10):1355-1360.
7. Gangireddy C, Rectenwald JR, Upchurch GR, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vascular Surg. 2007;45(2): 335-342.
8. Rosenfeld BA, Beattie C, Christopherson R, et al; Perioperative Ischemia Randomized Anesthesia Trial Study Group. The effects of different anesthetic regimens on fibrinolysis and the development of postoperative arterial thrombosis. Anesthesiology. 1993;79(3):435-443.
9. Byrnes JR, Wolberg AS. Red blood cells in thrombosis. Blood. 2017;130(16):1795-1799.
10. Litvinov RI, Weisel JW. Role of red blood cells in haemostasis and thrombosis. ISBT Sci Ser. 2017;12 (1):176-183.
11. Barr JD, Chauhan AK, Schaeffer GV, Hansen JK, Motto DG. Red blood cells mediate the onset of thrombosis in the ferric chloride murine model. Blood. 2013;121(18):3733-3741.
12. Donadee C, Raat NJ, Kanias T, et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation. 2011;124(4):465-476.
13. Liu C, Zhao W, Christ GJ, Gladwin MT, Kim-Shapiro DB. Nitric oxide scavenging by red cell microparticles. Free Radic Biol Med. 2013;65:1164-1173.
14. Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med. 2008;168(21):2377-2381.
15. Nelson RE, Grosse SD, Waitzman NJ, et al. Using multiple sources of data for surveillance of postoperative venous thromboembolism among surgical patients treated in Department of Veterans Affairs hospitals, 2005-2010. Thromb Res. 2015; 135(4):636-642.
16. Hod EA, Godbey EA. The outsider adverse event in transfusion: inflammation. Presse Med. 2016;45(7-8, pt 2):e325-e329.
17. Hod EA. Red blood cell transfusion-induced inflammation: myth or reality. ISBT Sci Ser. 2015;10 (suppl 1):188-191.
18. Zallen G, Moore EE, Ciesla DJ, Brown M, Biffl WL, Silliman CC. Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2. Shock. 2000;13(1):29-33.
19. Reynolds JD, Ahearn GS, Angelo M, Zhang J, Cobb F, Stamler JS. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A. 2007;104(43):17058-17062.
20. L’Acqua C, Bandyopadhyay S, Francis RO, et al. Red blood cell transfusion is associated with increased hemolysis and an acute phase response in a subset of critically ill children. Am J Hematol. 2015;90(10):915-920.
21. Walton BL, Lehmann M, Skorczewski T, et al. Elevated hematocrit enhances platelet accumulation following vascular injury. Blood. 2017; 129(18):2537-2546.
22. Machlus KR, Battinelli EM. RBCs pin platelets against the (thrombus) wall. Blood. 2017;129(18): 2460-2461.
23. Xenos ES, Vargas HD, Davenport DL. Association of blood transfusion and venous thromboembolism after colorectal cancer resection. Thromb Res. 2012;129(5):568-572.
24. Nilsson KR, Berenholtz SM, Garrett-Mayer E, Dorman T, Klag MJ, Pronovost PJ. Association between venous thromboembolism and perioperative allogeneic transfusion. Arch Surg. 2007;142(2):126-132.
25. Liu Y, Cohen ME, Hall BL, Ko CY, Bilimoria KY. Evaluation and enhancement of calibration in the American College of Surgeons NSQIP surgical risk calculator. J Am Coll Surg. 2016;223(2):231-239.
26. Mansmann U, Rieger A, Strahwald B, Crispin A. Risk calculators: methods, development, implementation, and validation. Int J Colorectal Dis. 2016;31(6):1111-1116.
27. Kaafarani HM, Mavros MN, Hwabejire J, et al. Derivation and validation of a novel severity classification for intraoperative adverse events. J Am Coll Surg. 2014;218(6):1120-1128.
28. Khuri SF, Daley J, Henderson W, et al; National VA Surgical Quality Improvement Program. The Department of Veterans Affairs’ NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. Ann Surg. 1998;228(4):491-507.
29. Daley J, Khuri SF, Henderson W, et al. Risk adjustment of the postoperative morbidity rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg. 1997;185 (4):328-340.
30. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011; 46(3):399-424.
31. Kahlert J, Gribsholt SB, Gammelager H, Dekkers OM, Luta G. Control of confounding in the analysis phase: an overview for clinicians. Clin Epidemiol. 2017;9:195-204.
32. Lunt M. Selecting an appropriate caliper can be essential for achieving good balance with propensity score matching. Am J Epidemiol. 2014; 179(2):226-235.
33. Duke WW. The relation of blood platelets to hemorrhagic disease. JAMA. 1910;55:1185-1192.
34. Blajchman MA, Bordin JO, Bardossy L, Heddle NM. The contribution of the haematocrit to thrombocytopenic bleeding in experimental animals. Br J Haematol. 1994;86(2):347-350.
35. Valeri CR, Cassidy G, Pivacek LE, et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion. 2001;41(8):977-983.
36. Uhl L, Assmann SF, Hamza TH, Harrison RW, Gernsheimer T, Slichter SJ. Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial. Blood. 2017;130(10):1247-1258.
37. Ho CH. The hemostatic effect of adequate red cell transfusion in patients with anemia and thrombocytopenia. Transfusion. 1996;36(3):290.
38. Schafer AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood. 1984;64(1):1-12.
39. Rossi C, Randi ML, Zerbinati P, Rinaldi V, Girolami A. Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med. 1998;244(1):49-53.
40. Stoltz JF, Donner M. New trends in clinical hemorheology: an introduction to the concept of the hemorheological profile. Schweiz Med Wochenschr Suppl. 1991;43:41-49.
41. Valles J, Santos MT, Aznar J, et al. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood. 1991;78(1):154-162.
42. Silvain J, Abtan J, Kerneis M, et al. Impact of red blood cell transfusion on platelet aggregation and inflammatory response in anemic coronary and noncoronary patients: the TRANSFUSION-2 study (Impact of Transfusion of Red Blood Cell on Platelet Activation and Aggregation Studied With Flow Cytometry Use and Light Transmission Aggregometry). J Am Coll Cardiol. 2014;63(13): 1289-1296.
43. Zimrin AB, Hess JR. Current issues relating to the transfusion of stored red blood cells. Vox Sang. 2009;96(2):93-103.
44. Chin-Yee I, Arya N, d’Almeida MS. The red cell storage lesion and its implication for transfusion. Transfus Sci. 1997;18(3):447-458.
45. Hess JR. Red cell storage. J Proteomics. 2010;73 (3):368-373.